Black Rock Inc. Statera Biopharma, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.08 - $0.23 $177 - $510	-2,220 Reduced 1.99%	109,531 $8,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $0.28 $447 - $964	-3,444 Reduced 2.99%	111,751 $14,000
Q2 2022 Aug 12, 2022	BUY	$0.21 - $0.38 $11,899 - $21,532	56,664 Added 96.81%	115,195 $32,000
Q1 2022 May 12, 2022	SELL	$0.31 - $2.27 $850 - $6,231	-2,745 Reduced 4.48%	58,531 $18,000
Q4 2021 Feb 10, 2022	BUY	$2.01 - $4.08 $84,480 - $171,482	42,030 Added 218.38%	61,276 $140,000
Q3 2021 Nov 09, 2021	BUY	$2.29 - $6.24 $44,073 - $120,095	19,246 New	19,246 $44,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.